Literature DB >> 25980608

Natural flavonoids as antidiabetic agents. The binding of gallic and ellagic acids to glycogen phosphorylase b.

Efthimios Kyriakis1, George A Stravodimos1, Anastassia L Kantsadi1, Demetra S M Chatzileontiadou1, Vassiliki T Skamnaki1, Demetres D Leonidas2.   

Abstract

We present a study on the binding of gallic acid and its dimer ellagic acid to glycogen phosphorylase (GP). Ellagic acid is a potent inhibitor with Kis of 13.4 and 7.5 μM, in contrast to gallic acid which displays Kis of 1.7 and 3.9 mM for GPb and GPa, respectively. Both compounds are competitive inhibitors with respect to the substrate, glucose-1-phoshate, and non-competitive to the allosteric activator, AMP. However, only ellagic acid functions with glucose in a strongly synergistic mode. The crystal structures of the GPb-gallic acid and GPb-ellagic acid complexes were determined at high resolution, revealing that both ligands bind to the inhibitor binding site of the enzyme and highlight the structural basis for the significant difference in their inhibitory potency.
Copyright © 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ellagic acid; Enzyme inhibition; Flavonoids; Gallic acid; Glycogen phosphorylase; Type 2 diabetes; X-ray crystallography

Mesh:

Substances:

Year:  2015        PMID: 25980608     DOI: 10.1016/j.febslet.2015.05.013

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  6 in total

1.  Therapeutic potentials of Crataegus azarolus var. eu- azarolus Maire leaves and its isolated compounds.

Authors:  Eman Abu-Gharbieh; Naglaa Gamil Shehab
Journal:  BMC Complement Altern Med       Date:  2017-04-18       Impact factor: 3.659

2.  Polarity directed optimization of phytochemical and in vitro biological potential of an indigenous folklore: Quercus dilatata Lindl. ex Royle.

Authors:  Madiha Ahmed; Humaira Fatima; Muhammad Qasim; Bilquees Gul
Journal:  BMC Complement Altern Med       Date:  2017-08-03       Impact factor: 3.659

3.  Gallic Acid Ameliorated Impaired Lipid Homeostasis in a Mouse Model of High-Fat Diet-and Streptozotocin-Induced NAFLD and Diabetes through Improvement of β-oxidation and Ketogenesis.

Authors:  Jung Chao; Hao-Yuan Cheng; Ming-Ling Chang; Shyh-Shyun Huang; Jiunn-Wang Liao; Yung-Chi Cheng; Wen-Huang Peng; Li-Heng Pao
Journal:  Front Pharmacol       Date:  2021-02-12       Impact factor: 5.810

4.  Ellagic Acid Effect on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Authors:  Gladys Maribel Hidalgo-Lozada; Angélica Villarruel-López; Esperanza Martínez-Abundis; Olga Vázquez-Paulino; Manuel González-Ortiz; Karina Griselda Pérez-Rubio
Journal:  J Clin Med       Date:  2022-09-28       Impact factor: 4.964

5.  Methylation and Acetylation Enhanced the Antidiabetic Activity of Some Selected Flavonoids: In Vitro, Molecular Modelling and Structure Activity Relationship-Based Study.

Authors:  Qamar Uddin Ahmed; Murni Nazira Sarian; Siti Zaiton Mat So'ad; Jalifah Latip; Solachuddin Jauhari Arief Ichwan; Nurlaili Najmie Hussein; Muhammad Taher; Alhassan Muhammad Alhassan; Hanisuhana Hamidon; Sharida Fakurazi
Journal:  Biomolecules       Date:  2018-11-15

6.  A phenolic small molecule inhibitor of RNase L prevents cell death from ADAR1 deficiency.

Authors:  Salima Daou; Manisha Talukdar; Jinle Tang; Beihua Dong; Shuvojit Banerjee; Yize Li; Nicole M Duffy; Abiodun A Ogunjimi; Christina Gaughan; Babal K Jha; Gerald Gish; Nicolas Tavernier; Daniel Mao; Susan R Weiss; Hao Huang; Robert H Silverman; Frank Sicheri
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-21       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.